Steve Schonfeld’s Precision BioSciences DTIL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.72M Buy
+274,388
New +$2.07M 0.01% 1254
2026
Q2
– Sell
-40,552
Closed -$223K – 2700
2026
Q1
$223K Buy
+40,552
New +$187K ﹤0.01% 1696
2023
Q2
– Sell
-343
Closed -$7.76K – 2222
2023
Q1
$7.76K Sell
343
-657
-66% -$21.6K ﹤0.01% 1876
2022
Q4
$35.7K Sell
1,000
-1,150
-53% -$45.4K ﹤0.01% 2285
2022
Q3
$83K Sell
2,150
-442
-17% -$21K ﹤0.01% 2588
2022
Q2
$124K Buy
2,592
+439
+20% +$25.8K ﹤0.01% 2075
2022
Q1
$199K Buy
+2,153
New +$293K ﹤0.01% 1970
2021
Q3
– Sell
-1,183
Closed -$444K – 2220
2021
Q2
$444K Buy
1,183
+656
+124% +$197K ﹤0.01% 1254
2021
Q1
$164K Buy
+527
New +$184K ﹤0.01% 1564

Other funds holding DTIL

Steve Schonfeld's DTIL Position: Q3 2026 in Review

Steve Schonfeld opened a new position in Precision BioSciences (DTIL) in Q3 2026: 274,388 shares worth $1.72M. The stake represents 0.01% of the portfolio and ranks #1254 among its holdings. This is a return to the name: Steve Schonfeld previously reported a position in DTIL as recently as Q1 2026.

Steve Schonfeld first reported a position in DTIL in Q1 2021 and has held it in 9 quarters since. 108 funds tracked by Wall St. Rank hold DTIL as of Q3 2026.

  • Steve Schonfeld held 274,388 shares of Precision BioSciences worth $1.72M as of Q3 2026.
  • Precision BioSciences was a new Steve Schonfeld position in Q3 2026.
  • Precision BioSciences made up 0.01% of Steve Schonfeld's portfolio in Q3 2026, its #1254 holding.
  • Steve Schonfeld first reported a position in Precision BioSciences in Q1 2021 and has held it in 9 quarters since.
  • 108 funds tracked by Wall St. Rank held Precision BioSciences as of Q3 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.